The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Transcervical Female Sterilization-Global Market Insights and Sales Trends 2025
Synopsis
Transcervical tubal sterilization. Transcervical sterilization or tubal occlusion is a procedure that offers permanent birth control for women. It is a highly effective, minimally invasive alternative to surgical tubal ligation.
The global Transcervical Female Sterilization market size is expected to reach US$ 957.4 million by 2029, growing at a CAGR of 4.2% from 2023 to 2029. The market is mainly driven by the significant applications of Transcervical Female Sterilization in various end use industries. The expanding demands from the Hospital and Clinic, are propelling Transcervical Female Sterilization market. Tubal Ligation, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Transcervical Implant segment is estimated at % CAGR for the next seven-year period.
The global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Transcervical Female Sterilization, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Transcervical Female Sterilization market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Transcervical Female Sterilization market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Transcervical Female Sterilization sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Transcervical Female Sterilization covered in this report include J & J, Medtronic, Karl Storz, Olympus, Applied Medical, Richard Wolf, Bayer AG, Stryker and B. Braun Aesculap, etc.
The global Transcervical Female Sterilization market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
J & J
Medtronic
Karl Storz
Olympus
Applied Medical
Richard Wolf
Bayer AG
Stryker
B. Braun Aesculap
ERBE
LiNA Medical
ConMed
Microline Surgical
Apollo Endosurgery
Global Transcervical Female Sterilization market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Transcervical Female Sterilization market, Segment by Type:
Tubal Ligation
Transcervical Implant
Global Transcervical Female Sterilization market, by Application
Hospital
Clinic
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Transcervical Female Sterilization companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Transcervical tubal sterilization. Transcervical sterilization or tubal occlusion is a procedure that offers permanent birth control for women. It is a highly effective, minimally invasive alternative to surgical tubal ligation.
The global Transcervical Female Sterilization market size is expected to reach US$ 957.4 million by 2029, growing at a CAGR of 4.2% from 2023 to 2029. The market is mainly driven by the significant applications of Transcervical Female Sterilization in various end use industries. The expanding demands from the Hospital and Clinic, are propelling Transcervical Female Sterilization market. Tubal Ligation, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Transcervical Implant segment is estimated at % CAGR for the next seven-year period.
The global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Transcervical Female Sterilization, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Transcervical Female Sterilization market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Transcervical Female Sterilization market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Transcervical Female Sterilization sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Transcervical Female Sterilization covered in this report include J & J, Medtronic, Karl Storz, Olympus, Applied Medical, Richard Wolf, Bayer AG, Stryker and B. Braun Aesculap, etc.
The global Transcervical Female Sterilization market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
J & J
Medtronic
Karl Storz
Olympus
Applied Medical
Richard Wolf
Bayer AG
Stryker
B. Braun Aesculap
ERBE
LiNA Medical
ConMed
Microline Surgical
Apollo Endosurgery
Global Transcervical Female Sterilization market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Transcervical Female Sterilization market, Segment by Type:
Tubal Ligation
Transcervical Implant
Global Transcervical Female Sterilization market, by Application
Hospital
Clinic
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Transcervical Female Sterilization companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Index1 Market Overview of Transcervical Female Sterilization
1.1 Transcervical Female Sterilization Market Overview
1.1.1 Transcervical Female Sterilization Product Scope
1.1.2 Transcervical Female Sterilization Market Status and Outlook
1.2 Global Transcervical Female Sterilization Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global Transcervical Female Sterilization Market Size by Region (2018-2029)
1.4 Global Transcervical Female Sterilization Historic Market Size by Region (2018-2023)
1.5 Global Transcervical Female Sterilization Market Size Forecast by Region (2024-2029)
1.6 Key Regions, Transcervical Female Sterilization Market Size (2018-2029)
1.6.1 North America Transcervical Female Sterilization Market Size (2018-2029)
1.6.2 Europe Transcervical Female Sterilization Market Size (2018-2029)
1.6.3 Asia-Pacific Transcervical Female Sterilization Market Size (2018-2029)
1.6.4 Latin America Transcervical Female Sterilization Market Size (2018-2029)
1.6.5 Middle East & Africa Transcervical Female Sterilization Market Size (2018-2029)
2 Transcervical Female Sterilization Market by Type
2.1 Introduction
2.1.1 Tubal Ligation
2.1.2 Transcervical Implant
2.2 Global Transcervical Female Sterilization Market Size by Type: 2018 VS 2022 VS 2029
2.2.1 Global Transcervical Female Sterilization Historic Market Size by Type (2018-2023)
2.2.2 Global Transcervical Female Sterilization Forecasted Market Size by Type (2024-2029)
2.3 Key Regions Market Size by Type
2.3.1 North America Transcervical Female Sterilization Revenue Breakdown by Type (2018-2029)
2.3.2 Europe Transcervical Female Sterilization Revenue Breakdown by Type (2018-2029)
2.3.3 Asia-Pacific Transcervical Female Sterilization Revenue Breakdown by Type (2018-2029)
2.3.4 Latin America Transcervical Female Sterilization Revenue Breakdown by Type (2018-2029)
2.3.5 Middle East and Africa Transcervical Female Sterilization Revenue Breakdown by Type (2018-2029)
3 Transcervical Female Sterilization Market Overview by Application
3.1 Introduction
3.1.1 Hospital
3.1.2 Clinic
3.2 Global Transcervical Female Sterilization Market Size by Application: 2018 VS 2022 VS 2029
3.2.1 Global Transcervical Female Sterilization Historic Market Size by Application (2018-2023)
3.2.2 Global Transcervical Female Sterilization Forecasted Market Size by Application (2024-2029)
3.3 Key Regions Market Size by Application
3.3.1 North America Transcervical Female Sterilization Revenue Breakdown by Application (2018-2029)
3.3.2 Europe Transcervical Female Sterilization Revenue Breakdown by Application (2018-2029)
3.3.3 Asia-Pacific Transcervical Female Sterilization Revenue Breakdown by Application (2018-2029)
3.3.4 Latin America Transcervical Female Sterilization Revenue Breakdown by Application (2018-2029)
3.3.5 Middle East and Africa Transcervical Female Sterilization Revenue Breakdown by Application (2018-2029)
4 Transcervical Female Sterilization Competition Analysis by Players
4.1 Global Transcervical Female Sterilization Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Transcervical Female Sterilization as of 2022)
4.3 Date of Key Players Enter into Transcervical Female Sterilization Market
4.4 Global Top Players Transcervical Female Sterilization Headquarters and Area Served
4.5 Key Players Transcervical Female Sterilization Product Solution and Service
4.6 Competitive Status
4.6.1 Transcervical Female Sterilization Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 J & J
5.1.1 J & J Profile
5.1.2 J & J Main Business
5.1.3 J & J Transcervical Female Sterilization Products, Services and Solutions
5.1.4 J & J Transcervical Female Sterilization Revenue (US$ Million) & (2018-2023)
5.1.5 J & J Recent Developments
5.2 Medtronic
5.2.1 Medtronic Profile
5.2.2 Medtronic Main Business
5.2.3 Medtronic Transcervical Female Sterilization Products, Services and Solutions
5.2.4 Medtronic Transcervical Female Sterilization Revenue (US$ Million) & (2018-2023)
5.2.5 Medtronic Recent Developments
5.3 Karl Storz
5.3.1 Karl Storz Profile
5.3.2 Karl Storz Main Business
5.3.3 Karl Storz Transcervical Female Sterilization Products, Services and Solutions
5.3.4 Karl Storz Transcervical Female Sterilization Revenue (US$ Million) & (2018-2023)
5.3.5 Olympus Recent Developments
5.4 Olympus
5.4.1 Olympus Profile
5.4.2 Olympus Main Business
5.4.3 Olympus Transcervical Female Sterilization Products, Services and Solutions
5.4.4 Olympus Transcervical Female Sterilization Revenue (US$ Million) & (2018-2023)
5.4.5 Olympus Recent Developments
5.5 Applied Medical
5.5.1 Applied Medical Profile
5.5.2 Applied Medical Main Business
5.5.3 Applied Medical Transcervical Female Sterilization Products, Services and Solutions
5.5.4 Applied Medical Transcervical Female Sterilization Revenue (US$ Million) & (2018-2023)
5.5.5 Applied Medical Recent Developments
5.6 Richard Wolf
5.6.1 Richard Wolf Profile
5.6.2 Richard Wolf Main Business
5.6.3 Richard Wolf Transcervical Female Sterilization Products, Services and Solutions
5.6.4 Richard Wolf Transcervical Female Sterilization Revenue (US$ Million) & (2018-2023)
5.6.5 Richard Wolf Recent Developments
5.7 Bayer AG
5.7.1 Bayer AG Profile
5.7.2 Bayer AG Main Business
5.7.3 Bayer AG Transcervical Female Sterilization Products, Services and Solutions
5.7.4 Bayer AG Transcervical Female Sterilization Revenue (US$ Million) & (2018-2023)
5.7.5 Bayer AG Recent Developments
5.8 Stryker
5.8.1 Stryker Profile
5.8.2 Stryker Main Business
5.8.3 Stryker Transcervical Female Sterilization Products, Services and Solutions
5.8.4 Stryker Transcervical Female Sterilization Revenue (US$ Million) & (2018-2023)
5.8.5 Stryker Recent Developments
5.9 B. Braun Aesculap
5.9.1 B. Braun Aesculap Profile
5.9.2 B. Braun Aesculap Main Business
5.9.3 B. Braun Aesculap Transcervical Female Sterilization Products, Services and Solutions
5.9.4 B. Braun Aesculap Transcervical Female Sterilization Revenue (US$ Million) & (2018-2023)
5.9.5 B. Braun Aesculap Recent Developments
5.10 ERBE
5.10.1 ERBE Profile
5.10.2 ERBE Main Business
5.10.3 ERBE Transcervical Female Sterilization Products, Services and Solutions
5.10.4 ERBE Transcervical Female Sterilization Revenue (US$ Million) & (2018-2023)
5.10.5 ERBE Recent Developments
5.11 LiNA Medical
5.11.1 LiNA Medical Profile
5.11.2 LiNA Medical Main Business
5.11.3 LiNA Medical Transcervical Female Sterilization Products, Services and Solutions
5.11.4 LiNA Medical Transcervical Female Sterilization Revenue (US$ Million) & (2018-2023)
5.11.5 LiNA Medical Recent Developments
5.12 ConMed
5.12.1 ConMed Profile
5.12.2 ConMed Main Business
5.12.3 ConMed Transcervical Female Sterilization Products, Services and Solutions
5.12.4 ConMed Transcervical Female Sterilization Revenue (US$ Million) & (2018-2023)
5.12.5 ConMed Recent Developments
5.13 Microline Surgical
5.13.1 Microline Surgical Profile
5.13.2 Microline Surgical Main Business
5.13.3 Microline Surgical Transcervical Female Sterilization Products, Services and Solutions
5.13.4 Microline Surgical Transcervical Female Sterilization Revenue (US$ Million) & (2018-2023)
5.13.5 Microline Surgical Recent Developments
5.14 Apollo Endosurgery
5.14.1 Apollo Endosurgery Profile
5.14.2 Apollo Endosurgery Main Business
5.14.3 Apollo Endosurgery Transcervical Female Sterilization Products, Services and Solutions
5.14.4 Apollo Endosurgery Transcervical Female Sterilization Revenue (US$ Million) & (2018-2023)
5.14.5 Apollo Endosurgery Recent Developments
6 North America
6.1 North America Transcervical Female Sterilization Market Size by Country (2018-2029)
6.2 the United States
6.3 Canada
7 Europe
7.1 Europe Transcervical Female Sterilization Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Transcervical Female Sterilization Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Transcervical Female Sterilization Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Transcervical Female Sterilization Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Transcervical Female Sterilization Market Dynamics
11.1 Transcervical Female Sterilization Industry Trends
11.2 Transcervical Female Sterilization Market Drivers
11.3 Transcervical Female Sterilization Market Challenges
11.4 Transcervical Female Sterilization Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest IT & Electronics Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
